Fluoxymesterone

氟甲睾酮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFluoxymesterone
Drug Alias NameFluotestin氟羟甲基睾丸酮氟羚甲基睾丸素UltandrenOratestin +[20] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsPuberty, DelayedHypogonadismBreast Neoplasms
Global Approved IndicationsPuberty, DelayedHypogonadismBreast Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1956/10/15
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & Upjohn
Active IndicationsN/A
Inactive IndicationsPuberty, DelayedHypogonadismBreast Neoplasms

Other Information

ATC CodeG03BA01
Related LinksWikipediaDrugBankKEGG